“From a patient care standpoint, anything that opens the door and makes the patient feel more secure and open is going to lead to better outcomes for them and allow us to serve their needs best,” says Benjamin Lowentritt, MD, FACS.
In this interview, Benjamin Lowentritt, MD, FACS, highlights key takeaways from the discussion “Appreciating Diversity in Urology Care”, which took place during the 2022 LUGPA Annual Meeting in Chicago, Illinois. Lowentritt is a practicing urologist at Chesapeake Urology in Baltimore, Maryland.
Pembrolizumab plus platinum-based therapy shows safety, efficacy in penile cancer
June 4th 2024“The HERCULES trial is the first trial to demonstrate the efficacy of immune checkpoint inhibitors in [patients with] advanced penile cancer with [a] manageable safety profile," says Fernando Cotait Maluf, MD.